Relation of CRP Level with the Severity of Coronary Artery Stenosis in Diabetic Patients
CRP Level and the severity of Coronary artery stenosis
Article Sidebar
Main Article Content
Abstract
Background: Atherosclerosis is a disease characterized by the deposition of lipids on the inner walls of blood vessels. Diabetes is a significant risk factor for atherosclerosis. C-reactive protein (CRP) is a marker of systemic inflammation and an independent risk factor for cardiovascular diseases (CVD). This study aimed to investigate the relationship between serum CRP levels and the severity of coronary artery disease in diabetic patients.
Materials and Methods: This descriptive-analytical study was conducted on 185 diabetic patients referred for coronary angiography based on non-invasive test indications. A checklist based on demographic information, blood pressure, and duration of diabetes was completed, and CRP testing was performed for each patient. Coronary angiographic data were also collected, including the type and severity of involved vessels reported by two cardiologists.
Results: There was a significant relationship between serum CRP level and the severity of coronary artery disease (P-value=0.009). Additionally, there was a significant relationship between the duration of diabetes and the severity of coronary artery disease (P-value=0.006).
Conclusion: We found a significant relationship between serum CRP levels and the severity of coronary artery stenosis and between the duration of diabetes and the severity of coronary artery stenosis.
Article Details
Copyright (c) 2025 Nough H.
This work is licensed under a Creative Commons Attribution 4.0 International License.
1. Ferrannini G, Manca ML, Magnoni M, Andreotti F, Andreini D, Latini R, et al. Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study. Diabetes Care. 2020;43(4):843-51.
2. Ramesh S.Besharat MB.Nough H. Relationship between worry and anger rumination with cardiovascular disease severity, social loneliness as a moderator.Archives of Iranian medicine 23(3).175-180,2020
3.SRamesh, MA Besharat, H Nough. Spiritual well-being and coronary artery diseases severity: Mediating effects of anger rumination and worry. Health Education Journal 80 (5), 501-512, 2021
4. A Jafarzadeh, A Esmaeeli-Nadimi, H Nough, et al. Serum levels of interleukin (IL)-13, IL-17 and IL-18 in patients with ischemic
The Anatolian Journal of Cardiology, 2009
5.Bouzidi N, Messaoud MB, Maatouk F, Gamra H, Ferchichi S. Relationship between high sensitivity C-reactive protein and angiographic severity of coronary artery disease. Journal of geriatric cardiology: JGC. 2020;17(5):256.
6.Blaum C, Brunner FJ, Kröger F, Braetz J, Lorenz T, Goßling A, et al. Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population. European Journal of Preventive Cardiology. 2019;28(2):152-8.
7.Bahrami A, Zarghami N, Khajehali L. Association between C-reactive protein and HbA1C among patients with type 2 diabetes mellitus. Iranian Journal of Diabetes and Metabolism. . 2007;6(3):263-7.
8.Brown MJ. The impact of clinical trials legislation on clinical pharmacology: problems and solutions. British journal of clinical pharmacology. 2009;67(5):487.
9. Virchow R. Thrombosis and emboli:(1846-1856): Science History Publ.; 1998.
10. Fryburg DA, Vassileva MT. Atherosclerosis drug development in jeopardy: the need for predictive biomarkers of treatment response. Science Translational Medicine. 2011;3(72):72cm6-cm6.
11.Carlens C, Hergens M-P, Grunewald J, Ekbom A, Eklund A, Hoglund CO, et al. Smoking, use of moist snuff, and risk of chronic inflammatory diseases. American journal of respiratory and critical care medicine. 2010;181(11):1217-22.
12. Lucci C, Cosentino N, Genovese S, Campodonico J, Milazzo V, De Metrio M, et al. Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus. Cardiovascular Diabetology. 2020;19:1-13.
13.Farrokhian A, Mahmoodian M, Bahmani F, Amirani E, Shafabakhsh R, Asemi Z. The influences of chromium supplementation on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease. Biological trace element research. 2020;194:313-20.
14. Liu Y, Yao Y, Tang X-f, Xu N, Jiang L, Gao Z, et al. Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention. Journal of Cardiology. 2020;75(1):60-5.
15. Sharif S, Van der Graaf Y, Cramer MJ, Kapelle LJ, de Borst GJ, Visseren FL, et al. Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes. Cardiovascular diabetology. 2021;20:1-8.
16. Anwer SS, Gardi NA. Correlation of High Sensitive C-Reactive Protein with the Extent of Coronary Atherosclerotic Disease. AMJ (Advanced Medical Journal). 2024;9(1):167-74.